Full Press Release Details
Shareholders Vote in Favour of All Resolutions at Its Annual General
DUBLIN--(BUSINESS WIRE)--July 20, 2012--ICON plc, (NASDAQ:ICLR)
(ISIN:IE0005711209), a global provider of outsourced development
services to the pharmaceutical, biotechnology and medical device
industries, today announced that all resolutions recommended by the
Board at the Annual General Meeting of the Company held on 19 July 2012
were duly passed by shareholders. These resolutions were set out in the
Notice of the Annual General Meeting sent to shareholders on 12 June
2012 and are available on the ICON plc website www.iconplc.com.
DISCLOSURE NOTICE: The information contained in this release is
as of July 20th, 2012. ICON assumes no obligation to update
forward-looking statements contained in this release. A description of
risks and uncertainties relating to ICON and its business can be found
in ICON's Annual Report and Form 20-F for the fiscal year ended December
31, 2011 and in its Reports of Foreign Issuer on Form 6-K filed with the
US Securities and Exchange Commission.
ICON plc is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. The Company
specialises in the strategic development, management and analysis of
programs that support clinical development - from compound selection to
Phase I-IV clinical studies. ICON currently has approximately 8,930
employees, operating from 83 locations in 40 countries.
Further information is available at www.iconplc.com
Chief Financial Officer
VP Investor Relations